FDA Inspection 907206 — Olympia Pharmaceuticals

Olympia Pharmaceuticals — FEI 3009724085

The FDA completed an inspection of Olympia Pharmaceuticals on December 4, 2014 in Orlando, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 4, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Orlando, FL (United States)

Citations

IDCFRDescription
117421 CFR 211.42(b)Product flow through building is inadequate
142121 CFR 211.42(c)(10)Aseptic Processing Area
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
143621 CFR 211.42(c)(10)(vi)Equipment to control conditions
145221 CFR 211.113(b)Validation lacking for sterile drug products
188321 CFR 211.165(a)Testing and release for distribution
191221 CFR 211.166(a)Written program not followed